Yahoo! FinanceHome - Yahoo! - Help

Market Guide

[ Stock Screener | Company & Fund Index | Financial Glossary ]

Profile - IRIDEX Corporation (NasdaqNM:IRIX)
As of 31-Aug-2001
Enter symbol:
symbol lookup

 
More Info: Quote | Chart | News | Profile | Research | SEC | Msgs | Insider | Financials | Reports
Location
1212 Terra Bella Avenue
Mountain View, CA 94043
Phone: (650) 940-4700
Fax: (650) 940-4710
Email: info@iridex.com
Employees (last reported count): 121
Financial Links
 ·Top Institutional Holders
 ·Top Mutual Fund Holders
 ·Analyst Upgrade/Downgrade History
 ·Historical Quote Data
 ·Raw SEC Filings at sec.gov
Competitors:
 ·Sector: Healthcare
 ·Industry: Medical Equipment & Supplies
Company Website
 ·Home Page

 ·Search Yahoo! for related links...

Ownership
·Insider and 5%+ Owners: 50%
·Institutional: 44% (87% of float)
(26 institutions)
·Net Inst. Selling: 33.0K shares (+1.13%)
(prior quarter to latest quarter)
More From Market Guide
 ·Highlights
 ·Performance
 ·Ratio Comparisons
Business Summary
IRIDEX Corporation is a worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The Company's products are sold in the United States predominantly through a direct sales force and internationally through 54 independent distributors into 74 countries. The Company's ophthalmology products treat eye diseases, including the three leading causes of irreversible blindness. The current family of ophthalmology laser systems includes the IRIS Medical OcuLight SL, OcuLight SLx, OcuLight GL and OcuLight GLx Laser Photocoagulation systems (each an OcuLight System). The Company's dermatology products, including the IRIDERM DioLite 532 Laser System, treat skin diseases, primarily vascular and pigmented lesions. Each ophthalmic and dermatologic system consists of a small, portable laser console and interchangeable delivery devices, primarily for hospital and office-based use by ophthalmologists and dermatologists.
More from Market Guide: Expanded Business Description

Financial Summary
Iridex provides semiconductor based laser systems used to treat eye diseases, including the three leading causes of irreversible blindness (macular degeneration, diabetic retinopathy and glaucoma). For the six months ended 6/01, revenues fell 24% to $12.8 million. Net loss from con't operations totalled $913 thousand vs. an income of $1.4 million. Results reflect decreased unit volumes due to a decreased consumer base for OcuLight GLx, along with reduced margins.
More from Market Guide: Significant Developments

Officers[Insider Trade Data]
FY2000 Compensation
PayExer

John Nehra, 52
Chairman
--  --  
Theodore Boutacoff, 54
Pres, Director and CEO
$218K--  
Robert Kamenski, 46
CFO and VP of Admin.
151K$9.6K
Eduardo Arias, 56
Sr. VP of Worldwide Sales
155K--  
Timothy Powers, 39
VP of Operations
154K--  
Dollar amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year.
More from Market Guide on Officers & Directors:
Expanded List, Bios, Compensation, Options
Statistics at a Glance -- NasdaqNM:IRIXAs of 31-Aug-2001
Price and Volume
52-Week Low
on 5-Apr-2001
$3.00 
Recent Price$4.20 
52-Week High
on 11-Sep-2000
$12.188
Beta1.33 
Daily Volume (3-month avg)22.6K
Daily Volume (10-day avg)65.0K
Stock Performance
[one-year price graph]
big chart [1d | 5d | 3m | 6m | 1y | 2y | 5y | max]
52-Week Change-49.5%
52-Week Change
relative to S&P500
-32.2%
Share-Related Items
Market Capitalization$28.4M
Shares Outstanding6.75M
Float3.40M
Dividends & Splits
Annual Dividendnone 
Last Splitnone 
Per-Share Data
Book Value (mrq)$4.27 
Earnings (ttm)$0.00 
Earnings (mrq)$0.00 
Sales (ttm)$4.18 
Cash (mrq)$1.63 
Valuation Ratios
Price/Book (mrq)0.98 
Price/Earnings (ttm)4,200.00 
Price/Sales (ttm)1.01 
Income Statements
Sales (ttm)$29.3M
EBITDA (ttm)-$25.0K
Income available to common (ttm)$76.0K
Profitability
Profit Margin (ttm)0.3%
Operating Margin (ttm)-3.0%
Fiscal Year
Fiscal Year EndsDec 30
Most recent quarter30-June-2001
Management Effectiveness
Return on Assets (ttm)0.22%
Return on Equity (ttm)0.26%
Financial Strength
Current Ratio (mrq)8.32 
Debt/Equity (mrq)0 
Total Cash (mrq)$11.0M
Short Interest
As of 8-Aug-2001
Shares Short0 
Shares Short
(Prior Month)
5,000 
Daily Volume24.0K
See Profile Help for a description of each item above;   K = thousands;   M = millions;   mrq = most-recent quarter;   ttm = trailing twelve months;   (as of 30-June-2001)

Market Guide offers more in-depth Company Research, Stock Screening, and Hottest Stocks and Industries on over 10,000 U.S. Equities.


Copyright © 2001 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Company information Copyright Market Guide. Historical chart data and daily updates provided by Commodity Systems, Inc. (CSI). Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Market Guide, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.